EGFR antisense DNA BB-401
Term · Oncology and biomedicine · MLC-T-ONC-013238
A recombinant, plasmid DNA expression vector encoding a 39 nucleotide (nt) short hairpin RNA (shRNA) specific for the epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Upon intratumoral administration, the EGFR antisense DNA BB-401 is taken up by tumor cells and shRNA is transcribed. The shRNA is converted into small interfering RNA (siRNA) via the RNA interference (RNAi) pathway. The siRNA targets and binds to EGFR RNA expressed by tumor cells. This blocks EGFR mRNA translation and prevents EGFR protein expression.
| Identifier | MLC-T-ONC-013238 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-EGFR ddRNAi BB-401; ddRNAi BB-401 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013238",
"term": "EGFR antisense DNA BB-401",
"field": "Oncology and biomedicine",
"definition": "A recombinant, plasmid DNA expression vector encoding a 39 nucleotide (nt) short hairpin RNA (shRNA) specific for the epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Upon intratumoral administration, the EGFR antisense DNA BB-401 is taken up by tumor cells and shRNA is transcribed. The shRNA is converted into small interfering RNA (siRNA) via the RNA interference (RNAi) pathway. The siRNA targets and binds to EGFR RNA expressed by tumor cells. This blocks EGFR mRNA translation and prevents EGFR protein expression.",
"synonyms": [
"anti-EGFR ddRNAi BB-401",
"ddRNAi BB-401"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/egfr-antisense-dna-bb-401/"
}
Record 6,427 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.